Acute Stroke — On the Threshold of a Therapy?
- 14 December 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (24) , 1632-1633
- https://doi.org/10.1056/nejm199512143332410
Abstract
Ischemic stroke may occur with sudden cruelty and, when not fatal, may deplete the resources of the patient, family, and community. The most effective treatments are directed at the underlying causes of the initial ischemic event, the prevention of recurrence, and the reduction of potential risk factors, but they do little for the stroke itself. The majority of ischemic strokes, roughly 80 percent, result from thromboembolic or atherothrombotic processes. This underscores the fact that stroke is a vascular disorder with neurologic consequences, and provides a basis for the use of antithrombotic agents as therapy. The idea of using plasminogen activators . . .Keywords
This publication has 11 references indexed in Scilit:
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995
- Termination of trial of streptokinase in severe acute ischaemic strokeThe Lancet, 1995
- The European Stroke Scale.Stroke, 1994
- Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.Stroke, 1994
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Intravenous recombinant tissue plasminogen activator in acute carotid artery territory strokeNeurology, 1992
- Thrombolytic Intervention in Acute Thrombotic and Embolic StrokeSeminars in Neurology, 1991
- ClinimetricsPublished by JSTOR ,1987
- THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSIONJAMA, 1958